本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

7.56
+0.02000.27%
盘后:7.54-0.0200-0.26%19:57 EDT
成交量:367.04万
成交额:2,787.07万
市值:16.55亿
市盈率:-5.35
高:7.75
开:7.60
低:7.36
收:7.54
52周最高:16.44
52周最低:6.23
股本:2.19亿
流通股本:1.85亿
量比:1.03
换手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
净资产收益率:-72.99%
总资产收益率:-34.95%
市净率:3.18
市盈率(LYR):-5.32

数据加载中...

2026/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]